These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2801758)

  • 1. Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator.
    Mylvaganam R; Ahn YS; Garcia RO; Kim CI; Harrington WJ
    Am J Med Sci; 1989 Oct; 298(4):215-20. PubMed ID: 2801758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose danazol therapy in idiopathic thrombocytopenic purpura.
    Ahn YS; Mylvaganam R; Garcia RO; Kim CI; Palow D; Harrington WJ
    Ann Intern Med; 1987 Aug; 107(2):177-81. PubMed ID: 3605896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol for the treatment of idiopathic thrombocytopenic purpura.
    Ahn YS; Harrington WJ; Simon SR; Mylvaganam R; Pall LM; So AG
    N Engl J Med; 1983 Jun; 308(23):1396-9. PubMed ID: 6682484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol therapy in refractory chronic immune thrombocytopenic purpura.
    Mazzucconi MG; Francesconi M; Falcione E; Ferrari A; Gandolfo GM; Ghirardini A; Tirindelli MC
    Acta Haematol; 1987; 77(1):45-7. PubMed ID: 3107321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of danazol in the management of chronic idiopathic thrombocytopenic purpura.
    Heyd J; Hershko C
    Isr J Med Sci; 1985 May; 21(5):418-20. PubMed ID: 4040506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danazol for the treatment of idiopathic thrombocytopenic purpura.
    Buelli M; Cortelazzo S; Viero P; Minetti B; Comotti B; Bassan R; Barbui T
    Acta Haematol; 1985; 74(2):97-8. PubMed ID: 3937423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids.
    Kotlarek-Haus S; Podolak-Dawidziak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):768-76. PubMed ID: 2453406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocytopenic purpura (ITP).
    Ambríz R; Pizzuto J; Morales M; Chávez G; Guillén C; Avilés A
    Nouv Rev Fr Hematol (1978); 1986; 28(5):275-9. PubMed ID: 3808937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of danazol in the treatment of refractory idiopathic thrombocytopenic purpura. A report of 22 cases.
    Fenaux P; Quiquandon I; Huart JJ; Caulier MT; Bauters F
    Nouv Rev Fr Hematol (1978); 1990; 32(2):143-6. PubMed ID: 2377446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-dose danazol therapy in idiopathic thrombocytopenic purpura].
    Nozaki H; Tanaka K; Yonekura S; Shimizu M; Komatsuda M; Nagao T; Arimori S
    Rinsho Ketsueki; 1990 Oct; 31(10):1750-1. PubMed ID: 2255068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of danazol therapy in chronic refractory idiopathic thrombocytopenic purpura].
    Dan K; Nomura T
    Rinsho Ketsueki; 1986 Sep; 27(9):1705-11. PubMed ID: 3543436
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of danazol in the management of chronic immune thrombocytopenic purpura.
    McVerry BA; Auger M; Bellingham AJ
    Br J Haematol; 1985 Sep; 61(1):145-8. PubMed ID: 4052322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol for children with immune thrombocytopenic purpura.
    Weinblatt ME; Kochen J; Ortega J
    Am J Dis Child; 1988 Dec; 142(12):1317-9. PubMed ID: 3195531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation by danazol in autoimmune thrombocytopenia.
    Mylvaganam R; Ahn YS; Harrington WJ; Kim CI
    Clin Immunol Immunopathol; 1987 Mar; 42(3):281-7. PubMed ID: 3493865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danazol therapy in immune thrombocytopenic purpura.
    Marwaha RK; Singh RP; Garewal G; Marwaha N; Prakash D; Sarode R
    Pediatr Hematol Oncol; 1990; 7(2):193-8. PubMed ID: 2206861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danazol therapy for idiopathic thrombocytopenic purpura (ITP).
    Nalli G; Sajeva MR; Maffé GC; Ascari E
    Haematologica; 1988; 73(1):55-7. PubMed ID: 3131205
    [No Abstract]   [Full Text] [Related]  

  • 17. Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.
    Kayser W; Euler HH; Schmitz N; Gassmann W; Löffler H; Asbeck F
    Blut; 1985 Dec; 51(6):401-4. PubMed ID: 3852685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.
    Edelmann DZ; Knobel B; Virag I; Meytes D
    Postgrad Med J; 1990 Oct; 66(780):827-30. PubMed ID: 2099421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of danazol in immune thrombocytopenic purpura.
    Schreiber AD; Chien P; Tomaski A; Cines DB
    N Engl J Med; 1987 Feb; 316(9):503-8. PubMed ID: 3807993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic peliosis after danazol therapy for idiopathic thrombocytopenic purpura (ITP).
    Cassi E; De' Paoli A; Tosi A
    Haematologica; 1985; 70(6):549-50. PubMed ID: 3938438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.